Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 29, 2014

View Archived Issues

The effect of bisphosphonate compounds in animal models of acute colitis

Recessive variant found in PCD deficiency with MODY-like diabetes

Invion updates on ongoing phase II trial of nadolol in mild asthma

Eutropics receives NCI contract to develop predictive tests for personalized AML treatment

Lipocine reports topline results from phase III trial of LPCN-1021

BerGenBio granted Wellcome Trust award for cancer development program

AstraZeneca discloses new FGFR-4 inhibitors

Reduced HYAL2 gene methylation in blood correlated with breast cancer

Safety and pharmacokinetics of ABT-767 in BRCA1 and BRCA2 germline tumors

FDA approves Vitekta

CHMP recommends approval of aclidinium bromide/formoterol fumarate

EMA recommends ketoconazole for approval in Cushing's syndrome

EMA committee recommends approval of Moventig

Roche divulges novel CB2 receptor agonists

Allergan discloses novel S1P1 receptor ligands

Roche discloses new agents for HCV infection

Genzyme presents promising data from 3-year follow up of CARE-MS I

New LRRK2 inhibitors disclosed by Merck & Co.

Application filed for marketing approval of remestemcel-L in Japan

Novartis applies for Japanese approval of panobinostat

EMA committee hands down positive opinion on Trulicity

FDA approves Iluvien for diabetic macular edema

Harvoni recommended for the treatment of chronic hepatitis C

EMA committee recommends European approval of Cyramza

Lixiana approved in Japan for additional indications

Signifor recommended by CHMP to treat patients with acromegaly

Boehringer Ingelheim's nintedanib receives positive opinion for second-line therapy of NSCLC

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...